3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Leuprorelin: new trials by email Literature Review of Leuprorelin trials Research Report on Leuprorelin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer Relugolix, Leuprorelin - Prostate Cancer | Phase 2 | Completed | Millennium Pharmaceuticals, Inc. | 136 | 2014-03-26 | 2018-05-09 |
| Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer Paclitaxel, Bevacizumab, Letrozole - Metastatic Breast Cancer | Phase 2 | Completed | Japan Breast Cancer Research Group | 160 | 2014-01-01 | 2022-08-04 |
| Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c Leuprorelin, Flutamide - Prostatic Neoplasms | Phase 2 | Completed | Takeda | 341 | 1996-12-01 | 2015-07-29 |
Prostatic Neoplasms (2) · Breast Neoplasms (1)
Japan Breast Cancer Research Group (1) · Millennium Pharmaceuticals, Inc. (1) · Takeda (1)
Canada (1) · Japan (1) · United States (1)
Masakazu Toi, MD, PhD (1) · Shigehira Saji, MD, PhD (1)